European Heart Journal - Cardiovascular Imaging,
Journal Year:
2024,
Volume and Issue:
25(10), P. e250 - e250
Published: Aug. 17, 2024
Journal
Article
Accepted
manuscript
Education
and
Information
to
Reduce
Aortic
Aneurysm
Mortality
Rates
Get
access
Michael
Huy
Cuong
Pham,
MD,
MD
Department
of
Cardiology,
The
Heart
Center,
Copenhagen
University
Hospital
-
Rigshospitalet,
Copenhagen,
DenmarkDepartment
Radiology,
Diagnostic
Denmark
Address
for
correspondence:
Cardiology
&
2014,
Rigshospitalet
Clinical
Medicine,
Faculty
Health
Medical
Sciences,
Blegdamsvej
9,
2100-CPH,
Denmark,
E-mail:
[email protected],
Phone:
+45
60590202
Mobile:
https://orcid.org/0000-0002-6577-0079
Search
other
works
by
this
author
on:
Oxford
Academic
PubMed
Google
Scholar
Shoaib
Afzal,
PhD,
DMSc,
DMSc
https://orcid.org/0000-0002-1442-4694
Klaus
Fuglsang
Kofoed,
https://orcid.org/0000-0001-9742-1554
European
Cardiovascular
Imaging,
jeae208,
https://doi.org/10.1093/ehjci/jeae208
Published:
17
August
2024
history
Received:
24
July
Accepted:
09
Reviews in Cardiovascular Medicine,
Journal Year:
2025,
Volume and Issue:
26(2)
Published: Feb. 20, 2025
Background:
Lowering
low-density
lipoprotein
cholesterol
(LDL-C)
is
a
well-established
strategy
for
the
secondary
prevention
of
coronary
heart
disease
(CHD).
However,
effectiveness
specific
LDL-C
parameters
in
predicting
myocardial
infarction
(MI)
recurrence
real-world
settings
remains
inadequately
explored.
This
study
aims
to
examine
relationship
between
MI
and
various
young
CHD
patients.
Methods:
retrospective
cohort
involved
1013
patients
aged
18–44
at
time
initial
diagnosis,
collected
from
cardiology
department
clinics
Beijing
Anzhen
Hospital
October
2022
2023.
levels
were
assessed
diagnosis
final
follow-up.
The
primary
outcome
was
events,
analyzed
using
survival
analysis
logistic
regression
models
determine
associations
with
parameters.
Results:
included
(mean
age:
38.5
±
3.9
years;
94.7%
men),
median
follow-up
1.7
years.
Initially,
13.6%
had
<1.8
mmol/L,
which
increased
37.8%
by
study’s
end.
During
follow-up,
96
(9.5%)
experienced
MI.
While
mmol/L
baseline
showed
slightly
lower
cumulative
incidence
than
≥1.8
difference
not
statistically
significant
(log-rank
p
=
0.335).
Reductions
≥50%
patterns
change
did
correlate
decreased
risk.
<1.4
measurement
associated
reduced
risk
(adjusted
odds
ratio
[OR]:
0.57,
95%
confidence
interval
[CI]:
0.33–0.98)
compared
≥2.6
mmol/L.
Conclusions:
suggests
that
most
important
parameter
related
history
ideal
target
level.
could
potentially
reduce
risk,
regardless
levels.
GeroScience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 17, 2025
Abstract
Little
is
known,
how
life-long
hyperlipidaemia
affects
vascular
ageing,
before
atherosclerosis.
Here,
we
characterise
effects
of
mild,
on
age-dependent
endothelial
dysfunction
(ED)
in
humanised
dyslipidaemia
model
E3L.CETP
mice.
Vascular
function
was
characterised
using
magnetic
resonance
imaging
vivo
and
wire
myograph
ex
vivo.
Plasma
biomarkers
non-targeted
proteomics
plasma
aorta
were
analysed.
Early
atherosclerosis
lesions
occasionally
present
only
40-week-old
or
older
However,
ED
developed
earlier,
14-week-old
male
22-week-old
female
mice
as
compared
with
C57BL/6J
Acetylcholine-induced
vasodilation
8-week-old
E3L.CETP,
especially
mice,
blocked
by
catalase
attributed
to
H
2
O
.
In
changes
proteome
response
modest,
while
a
number
differentially
expressed
proteins
identified
that
involved
oxidative
stress
response,
inflammation
regulation
metabolic
pathways.
contrast,
either
aortic
displayed
similar
pattern
dominating
over
hyperlipidaemia-induced
changes.
Interestingly,
48-week-old
but
not
mitochondrial
functional
impaired.
resilience
detrimental
young
level
associated
switch
mechanism,
blunted
systemic
proteomic
slower
development
The
results
indicate
profile
early
risk
factors
age
may
determine
development.
Journal of Nanobiotechnology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: April 23, 2025
Atherosclerosis
is
a
complex
cardiovascular
disease
driven
by
multiple
factors,
including
aging,
inflammation,
oxidative
stress,
and
plaque
rupture.
The
progression
of
this
often
covert,
emphasizing
the
need
for
early
biomarkers
effective
intervention
measures.
In
recent
years,
advancements
in
therapeutic
strategies
have
highlighted
potential
targeting
specific
processes
atherosclerosis,
such
as
localization,
macrophage
activity,
key
enzymes.
Based
on
this,
review
discusses
role
targeted
drugs
treatment
atherosclerosis.
It
also
focuses
their
clinical
efficacy
anti-atherosclerosis
ability
to
provide
more
precise
approaches.
findings
underscore
that
future
research
can
concentrate
exploring
newer
drug
delivery
systems
further
refine
enhance
long-term
dynamic
management
Journal of Atherosclerosis and Thrombosis,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
Atherosclerotic
cardiovascular
disease
(ASCVD)
is
a
leading
global
cause
of
mortality,
and
recent
research
has
underscored
the
critical
role
lipoproteins
in
modulating
(CV)
risk.
Elevated
low-density
lipoprotein
cholesterol
(LDL-C)
levels
have
been
linked
to
increased
CV
events,
while
numerous
trials
confirmed
efficacy
lipid-lowering
therapies
(LLT),
significant
gaps
remain
between
recommended
LDL-C
targets
real-world
clinical
practice.
This
review
addresses
care
LLT,
emphasizing
necessity
for
innovative
approaches
that
extend
beyond
management.
It
explores
combination
therapy
such
as
statins
combined
with
ezetimibe
or
PCSK9
inhibitors,
which
shown
promise
enhancing
reduction
improving
outcomes
high-risk
patients.
Additionally,
this
discusses
new
lipid
modification
strategies,
including
bempedoic
acid,
inclisiran,
drugs
lower
Lp(a),
highlighting
their
potential
risk
reduction.
Furthermore,
it
emphasizes
polygenic
scores
guide
LLT
lifestyle
changes
despite
challenges
implementation
genetic
testing
ethics.
article
current
guidelines
proposes
optimizing
management,
ultimately
contributing
improved
patient
ASCVD
prevention.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 18, 2024
Abstract
Atherosclerotic
cardiovascular
disease,
the
leading
cause
of
global
mortality,
is
driven
by
lipid
accumulation
and
plaque
formation
within
arterial
walls.
Carotid
plaques,
detectable
via
ultrasound,
are
a
well-established
marker
subclinical
atherosclerosis.
In
this
study,
we
trained
deep
learning
model
to
detect
plaques
in
177,757
carotid
ultrasound
images
from
19,499
UK
Biobank
(UKB)
participants
(aged
47-83
years)
assess
prevalence,
risk
factors,
prognostic
significance,
genetic
architecture
atherosclerosis
large
population-based
cohort.
The
demonstrated
high
performance
metrics
with
accuracy,
sensitivity,
specificity,
positive
predictive
value
89.3%,
89.5%,
89.2%,
82.9%,
respectively,
identifying
45%
population.
Plaque
presence
count
were
significantly
associated
future
events
over
median
follow-up
period
up
7
years,
improved
reclassification
beyond
established
clinical
prediction
models.
A
genome-wide
association
study
(GWAS)
meta-analysis
(29,790
cases,
36,847
controls)
uncovered
two
novel
genomic
loci
(p
<
5×10
−8
)
downstream
analyses
implicating
lipoprotein(a)
interleukin-6
signaling,
both
targets
investigational
drugs
advanced
development.
Observational
Mendelian
randomization
showed
associations
between
smoking,
low-density-lipoprotein
(LDL)
cholesterol,
blood
pressure
odds
presence.
Our
underscores
potential
assessment
for
improving
prediction,
provides
insights
into
basis
atherosclerosis,
offers
valuable
resource
advancing
research
at
population
scale.
European Heart Journal - Cardiovascular Imaging,
Journal Year:
2024,
Volume and Issue:
25(10), P. e250 - e250
Published: Aug. 17, 2024
Journal
Article
Accepted
manuscript
Education
and
Information
to
Reduce
Aortic
Aneurysm
Mortality
Rates
Get
access
Michael
Huy
Cuong
Pham,
MD,
MD
Department
of
Cardiology,
The
Heart
Center,
Copenhagen
University
Hospital
-
Rigshospitalet,
Copenhagen,
DenmarkDepartment
Radiology,
Diagnostic
Denmark
Address
for
correspondence:
Cardiology
&
2014,
Rigshospitalet
Clinical
Medicine,
Faculty
Health
Medical
Sciences,
Blegdamsvej
9,
2100-CPH,
Denmark,
E-mail:
[email protected],
Phone:
+45
60590202
Mobile:
https://orcid.org/0000-0002-6577-0079
Search
other
works
by
this
author
on:
Oxford
Academic
PubMed
Google
Scholar
Shoaib
Afzal,
PhD,
DMSc,
DMSc
https://orcid.org/0000-0002-1442-4694
Klaus
Fuglsang
Kofoed,
https://orcid.org/0000-0001-9742-1554
European
Cardiovascular
Imaging,
jeae208,
https://doi.org/10.1093/ehjci/jeae208
Published:
17
August
2024
history
Received:
24
July
Accepted:
09